SI3056492T1 - Sol meglumina in njene kristalinične oblike zdravila (delafloksacin) - Google Patents
Sol meglumina in njene kristalinične oblike zdravila (delafloksacin)Info
- Publication number
- SI3056492T1 SI3056492T1 SI200532302T SI200532302T SI3056492T1 SI 3056492 T1 SI3056492 T1 SI 3056492T1 SI 200532302 T SI200532302 T SI 200532302T SI 200532302 T SI200532302 T SI 200532302T SI 3056492 T1 SI3056492 T1 SI 3056492T1
- Authority
- SI
- Slovenia
- Prior art keywords
- delafloxacin
- drug
- crystalline forms
- meglumine salt
- meglumine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C31/00—Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C31/18—Polyhydroxylic acyclic alcohols
- C07C31/26—Hexahydroxylic alcohols
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61733404P | 2004-10-08 | 2004-10-08 | |
| EP15199355.7A EP3056492B1 (en) | 2004-10-08 | 2005-10-07 | Meglumine salt and crystalline forms thereof of a drug (delafloxacin) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI3056492T1 true SI3056492T1 (sl) | 2022-03-31 |
Family
ID=36129950
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200532302T SI3056492T1 (sl) | 2004-10-08 | 2005-10-07 | Sol meglumina in njene kristalinične oblike zdravila (delafloksacin) |
Country Status (13)
| Country | Link |
|---|---|
| US (8) | US7728143B2 (sl) |
| EP (3) | EP3957632A1 (sl) |
| CA (1) | CA2582954C (sl) |
| CY (1) | CY1125048T1 (sl) |
| DK (1) | DK3056492T3 (sl) |
| ES (1) | ES2901955T3 (sl) |
| HU (1) | HUE056718T2 (sl) |
| LT (1) | LT3056492T (sl) |
| MX (1) | MX2007004111A (sl) |
| PL (1) | PL3056492T3 (sl) |
| PT (1) | PT3056492T (sl) |
| SI (1) | SI3056492T1 (sl) |
| WO (1) | WO2006042034A2 (sl) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7576216B2 (en) | 2004-07-30 | 2009-08-18 | Abbott Laboratories | Preparation of pyridonecarboxylic acid antibacterials |
| HUE056718T2 (hu) * | 2004-10-08 | 2022-03-28 | Abbvie Inc | Hatóanyag (delafloxacin) meglumin sója és ennek kristályos formái |
| MX2007012642A (es) * | 2005-04-11 | 2008-01-11 | Abbott Lab | Composiciones farmaceuticas que tienen perfiles mejorados de disolucion para farmacos poco solubles. |
| DK2346855T3 (en) | 2008-09-24 | 2017-07-24 | Melinta Therapeutics Inc | PROCEDURE FOR PREPARING QUINOLONE COMPOSITIONS |
| JP6063123B2 (ja) | 2008-11-15 | 2017-01-18 | メリンタ セラピューティクス、インク | 抗菌性組成物 |
| CA2903755A1 (en) * | 2013-03-08 | 2014-09-12 | Melinta Therapeutics, Inc. | Crystalline forms of d-glucitol, 1-deoxy-1-(methylamino)-, 1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-1,4-dihydro-7-(3-hydroxyazetidin-1-yl)-4-oxo-3-quinolinecarboxylate |
| TW201605447A (zh) * | 2014-06-20 | 2016-02-16 | 美林塔治療學有限公司 | 處理感染的方法 |
| TWI732337B (zh) * | 2014-06-20 | 2021-07-01 | 美商梅琳塔有限責任公司 | 醫藥組成物及其用途 |
| MX2017006319A (es) | 2014-11-14 | 2017-08-10 | Melinta Therapeutics Inc | Método para tratar, prevenir o reducir el riesgo de infección cutánea. |
| CN105693695A (zh) * | 2014-11-24 | 2016-06-22 | 重庆医药工业研究院有限责任公司 | 一种德拉沙星葡甲胺盐的晶型及其制备方法 |
| CN106256824B (zh) * | 2015-06-18 | 2020-10-27 | 重庆医药工业研究院有限责任公司 | 一种高纯度德拉沙星葡甲胺盐的制备方法 |
| CN105017223B (zh) * | 2015-07-08 | 2017-08-01 | 扬子江药业集团有限公司 | 德拉沙星葡甲胺晶型i及其制备方法 |
| CN105017224A (zh) * | 2015-07-10 | 2015-11-04 | 扬子江药业集团有限公司 | 一种德拉沙星葡甲胺晶型的制备方法 |
| CN106916142A (zh) * | 2015-12-25 | 2017-07-04 | 江苏奥赛康药业股份有限公司 | 一种制备高纯度德拉沙星的方法 |
| CN111718329A (zh) * | 2019-03-23 | 2020-09-29 | 南京海润医药有限公司 | 一种德拉沙星杂质iv及产品精制方法 |
| CN111718330A (zh) * | 2019-03-23 | 2020-09-29 | 南京海润医药有限公司 | 一种德拉沙星杂质iii及产品精制方法 |
| CN111718331A (zh) * | 2019-03-23 | 2020-09-29 | 南京海润医药有限公司 | 德拉沙星的杂质i和ii及产品精制方法 |
| WO2022240897A1 (en) | 2021-05-10 | 2022-11-17 | Sepelo Therapeutics, Llc | Pharmaceutical composition comprising delafloxacin for administration into the lung |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1207994B (it) | 1986-01-03 | 1989-06-01 | Therapicon Srl | Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche. |
| US5578609A (en) | 1994-03-25 | 1996-11-26 | The Dupont Merck Pharmaceutical Company | 2-carbocyclic and 2-heterocyclic quinoline-4-carboxylic acids and salts thereof useful as immunosuppressive agents |
| ES2177644T3 (es) | 1994-04-12 | 2002-12-16 | Arakis Ltd | Procedimiento para la resolucion de etodolac utilizando derivados de glucamina. |
| PT911327E (pt) * | 1995-09-22 | 2002-05-31 | Wakunaga Pharma Co Ltd | Novos derivados do acido piridonocarboxilico ou seus sais e agente antibacteriano compreendendo os mesmos como o ingrediente activo |
| EP0945134A1 (de) | 1998-03-27 | 1999-09-29 | Boehringer Ingelheim Pharma KG | Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation |
| JP2005097116A (ja) | 1999-11-11 | 2005-04-14 | Wakunaga Pharmaceut Co Ltd | キノリンカルボン酸誘導体アルカリ金属塩及びこれを用いたキノリンカルボン酸誘導体の精製法 |
| GB9929037D0 (en) * | 1999-12-08 | 2000-02-02 | Glaxo Wellcome Spa | Heterocyclic derivatives |
| JP2003522165A (ja) | 2000-01-31 | 2003-07-22 | ファイザー・プロダクツ・インク | Ｐｄｅ４アイソザイムの阻害剤として有用なピリミジンカルボキサミド |
| JP4337283B2 (ja) | 2001-07-11 | 2009-09-30 | ソニー株式会社 | 光ピックアップ装置及び記録及び／又は再生装置 |
| JP4290381B2 (ja) | 2002-04-11 | 2009-07-01 | 学校法人 聖マリアンナ医科大学 | ピリドンカルボン酸化合物含有エマルション |
| JP2004168772A (ja) | 2002-11-06 | 2004-06-17 | Takeda Chem Ind Ltd | 受容体調節剤 |
| HUE056718T2 (hu) * | 2004-10-08 | 2022-03-28 | Abbvie Inc | Hatóanyag (delafloxacin) meglumin sója és ennek kristályos formái |
-
2005
- 2005-10-07 HU HUE15199355A patent/HUE056718T2/hu unknown
- 2005-10-07 EP EP21196428.3A patent/EP3957632A1/en active Pending
- 2005-10-07 WO PCT/US2005/036024 patent/WO2006042034A2/en active Application Filing
- 2005-10-07 PL PL15199355T patent/PL3056492T3/pl unknown
- 2005-10-07 EP EP15199355.7A patent/EP3056492B1/en active Active
- 2005-10-07 US US11/245,561 patent/US7728143B2/en active Active
- 2005-10-07 LT LTEP15199355.7T patent/LT3056492T/lt unknown
- 2005-10-07 ES ES15199355T patent/ES2901955T3/es active Active
- 2005-10-07 SI SI200532302T patent/SI3056492T1/sl unknown
- 2005-10-07 PT PT151993557T patent/PT3056492T/pt unknown
- 2005-10-07 MX MX2007004111A patent/MX2007004111A/es active IP Right Grant
- 2005-10-07 DK DK15199355.7T patent/DK3056492T3/da active
- 2005-10-07 EP EP05825344A patent/EP1802607A2/en not_active Withdrawn
- 2005-10-09 CA CA2582954A patent/CA2582954C/en active Active
-
2010
- 2010-02-05 US US12/701,254 patent/US8252813B2/en active Active
- 2010-04-20 US US12/763,476 patent/US8273892B2/en active Active
-
2012
- 2012-08-27 US US13/595,585 patent/US8648093B2/en active Active
-
2014
- 2014-02-07 US US14/175,621 patent/US8969569B2/en active Active
-
2015
- 2015-02-03 US US14/612,879 patent/US9539250B2/en active Active
-
2016
- 2016-11-23 US US15/359,734 patent/US9873681B2/en active Active
-
2017
- 2017-12-18 US US15/844,904 patent/US10329276B2/en active Active
-
2021
- 2021-12-21 CY CY20211101121T patent/CY1125048T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3056492T3 (pl) | Sól megluminowa i jej krystaliczne postaci leku (delafloksacyna) | |
| HUS2400006I1 (hu) | Egy 4-oxokinolin-vegyület stabil kristályát tartalmazó kombináció | |
| HK1139681A1 (en) | Salts of valsartan | |
| IL206888A0 (en) | Compound capable of binding s1p receptor and pharmaceutical use thereof | |
| HK1104974A1 (en) | Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof | |
| IL181524A0 (en) | Heterocyclic compounds and methods of use | |
| EP1809282A4 (en) | THIADIAZOLE COMPOUNDS AND METHODS OF USE | |
| IL183245A0 (en) | Process for preparing phamaceutically acceptable salts of duloxetine and intermediates thereof | |
| HK1089783A1 (en) | Azo compound and salt thereof | |
| ZA200609205B (en) | Crystalline forms of duloxetine free base | |
| IL176141A0 (en) | Crystalline forms of valacyclovir hydrochloride | |
| EP1812451A4 (en) | COMPOUNDS AND METHODS OF USE THEREOF | |
| PL1802329T3 (pl) | Formulacja farmaceutyczna zawierająca krystaliczną insulinę oraz rozpuszczoną insulinę | |
| HK1092156A1 (en) | New 3-decladinosyl 9A-N-carbamoyl and 9A-N-thiocarbamoyl derivatives of 9-deox-9-di-hydro-9A-aza-9A homoerythromycin a | |
| ZA200608305B (en) | Pharmaceutical composition comprising a salt of mirtazapine | |
| PT1833810T (pt) | Modificações cristalinas de n-alfa-(2,4,6-triisopropil-fenilsulfonil)-3-hidroxiamidino-(l)-fenilalanina-4--etoxicarbonilpiperazida e/ou seus sais | |
| EP1744742A4 (en) | CRYSTALLINE FORMS AND AMORPHOUS SODIUM EFAPROXIRAL | |
| EP1677781A4 (en) | SALTS OF PHARMACOLOGICALLY ACTIVE COMPOUNDS | |
| IL177451A0 (en) | Crystalline forms of a pharmaceutical compound | |
| HK1102087A1 (en) | Crystalline forms of a pharmaceutical compound | |
| GB0313207D0 (en) | Use of a basic curd composition and derivatives thereof | |
| IL177990A0 (en) | Rotatable head of enarthrotic prosthesis | |
| GB0425532D0 (en) | Therapeutic compounds and methods for their preparation and use |